Schedule 13G ownership disclosure
CASI PHARMACEUTICALS INC
Security class unavailable · CUSIP: 14757U109
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,401,296
- Percent of class
- 4.3600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-21-001031
- Form type
- SC 13G
- Filer
- CASI Pharmaceuticals, Inc (DE)
- CIK
- CIK 895051
- Filed
- Feb 17, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership